Lisa Littner: The Hidden Burden of Prior Authorization in Bleeding Disorder Care
Lisa Littner, Hemophilia Treatment Center Program Manager at Cincinnati, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Haemophilia, adding:
”I am excited to share that my doctoral research on the Burden of Prior Authorization in Bleeding Disorder Specialty Drugs was published this week.
A special thanks to my co-authors, Jami Jones, Trudie Milner, and Elinor Borgert.
Thanks also to the Hemophilia Alliance Foundation for their support and to the Hemophilia Treatment Center staff who participated in this research.”
Title: The Burden of Prior Authorizations in Bleeding Disorder Specialty Drugs
Authors: Lisa Littner, Jami Jones, Trudie Milner, Elinor Borgert
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 4, 2026, 13:54Ahmad G. Alzahrani: A New Classification for Acute Pulmonary Embolism
-
Sep 4, 2026, 12:52James P. Crowley: MDS vs MPN – Understanding the Difference
-
Sep 4, 2026, 12:02Khalid Abdelsamea Mohamedahmed: Routine Blood Parameters in Pediatric Sickle Cell Anemia
-
Sep 4, 2026, 11:37Consuela A. Albright: The Power of Community Advocacy in Sickle Cell Disease
-
Sep 4, 2026, 11:18Aanika Roshni: When Blood, Biology, and Mechanics Intersect
-
Sep 4, 2026, 10:01Ifeanyichukwu Ifechidere: Making Coagulation Simpler and More Practical
-
Sep 4, 2026, 09:49Omid Khalafi: When the ‘Rules of Three’ Break – What Is Really Happening?
-
Sep 4, 2026, 09:27Hilly Paige: What ESC 2026 Taught Us About LDL-C Management
-
Sep 4, 2026, 05:38Faizan Khan: Why Common Exposures Matter in VTE Risk